Is BPC 157 Legal? Understanding Its Status and Implications FDA to weigh easing limits on peptides promoted by RFK Jr. NBC 6 South Florida The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York RFK Jr pushes for FDA approval of BPC 157 peptide Eric Topol, MD posted on the topic LinkedIn FDA Targets GLP 1 and Peptide Compounding, Advertising and 'Research Use Only' Labeling